DCI Center for Prostate & Urologic Cancers

1.8K posts

DCI Center for Prostate & Urologic Cancers banner
DCI Center for Prostate & Urologic Cancers

DCI Center for Prostate & Urologic Cancers

@DukeGUCancer

A multidisciplinary center within @DukeCancer focused on patient care and cutting-edge clinical, translational and population research.

Durham, NC Katılım Mayıs 2018
200 Takip Edilen1.2K Takipçiler
DCI Center for Prostate & Urologic Cancers retweetledi
Duke Clinical and Translational Science Institute
We proudly present our 2022 impact report, highlighting valuable contributions to advancing science, research, and health equity and the great work we have achieved with our partners. CTSI Translational Impact: Advancing Equity Read the report ➡️ sites.duke.edu/ctsiimpact2022/
Duke Clinical and Translational Science Institute tweet media
English
0
12
14
0
DCI Center for Prostate & Urologic Cancers retweetledi
The PCCTC
The PCCTC@ThePCCTC·
Study by esteemed PCCTC investigator @Daniel_J_George (@DukeGUCancer) and colleagues finds black men with chemotherapy-naïve metastatic prostate cancer initiating novel hormonal therapy may have better outcomes than similarly treated white men nature.com/articles/s4139…
The PCCTC tweet media
English
0
2
10
0
DCI Center for Prostate & Urologic Cancers retweetledi
Andrew Armstrong
Andrew Armstrong@AarmstrongDuke·
Join us for spring break at Disney! The Duke Urologic Assembly 2022 is on! Both in person and hybrid options are available with a great team of expert speakers for this CME event focused on precision urologic oncology and urology: @DukeGUCancer mailchi.mp/7bf30a6ae09a/a…
English
0
1
5
0
DCI Center for Prostate & Urologic Cancers retweetledi
DCI Center for Prostate & Urologic Cancers retweetledi
Sumanta K. Pal, MD, FASCO
Hard to believe @OncHahn is a fellow; during his time at @huntsmancancer & now @MDAndersonNews he has been incredibly prolific. No surprise with mentors like @neerajaiims. Terrific paper w @Daniel_J_George @DukeGUCancer. Great insight & graphics that are sure to appear at #GU22.
Neeraj Agarwal, MD, FASCO@neerajaiims

Just in @CCR_AACR : Our commentary on work by @StephaneTERRY1 👉⬆️tumor AXL expression associated with ⬇️response to anti-PD-1 therapy. AXL may be a biomarker & Rx target in metastatic #kidneycancer Wonderful job by @OncHahn bit.ly/3B4SJoR @OncoAlert @Daniel_J_George

English
1
8
33
0
DCI Center for Prostate & Urologic Cancers retweetledi
Judd Moul
Judd Moul@JuddMoul·
One week to go until #AUA21. Looking forward to debate with @LiMingSu1 on pros and cons of maintaining open RRP experience for urology residency training. Friday September 10th live during plenary session. @DukeUrology @DukeCancer @DukeGUCancer
Judd Moul tweet media
Oak Island, NC 🇺🇸 English
6
5
59
0
DCI Center for Prostate & Urologic Cancers retweetledi
OncLive SOSS
OncLive SOSS@OncLiveSOSS·
.@TiansterZhang, of @DukeCancer, discussed key considerations regarding frontline immunotherapy-based combinations in RCC and recent data from pivotal trials examining their use #kcsm ow.ly/Wy4Q50FVaup
OncLive SOSS tweet media
English
0
5
16
0
DCI Center for Prostate & Urologic Cancers retweetledi
Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)
Congratulations @TracyLRoseMD @MattMilowsky on your publication! Was great to enroll & treat patients on the trial @DukeGUCancer. More data for neoadjuvant IO-chemo for muscle invasive #bladdercancer. @BladderCancerUS @Daniel_J_George @DrChrisHoimes @AarmstrongDuke 👏👏
Matt Milowsky@MattMilowsky

Inimitable @TracyLRoseMD @UNCUroOnc @UNCurology @UNC_Lineberger with @MRHarrisonMD & outstanding colleagues @DukeGUCancer publishes in @JCO_ASCO Ph2 neoadjuvant chemo-IO with promising 56% <pT2 rate. Continued progress in #BladderCancer. @BladderCancerUS ascopubs.org/doi/abs/10.120…

English
0
4
13
0
DCI Center for Prostate & Urologic Cancers retweetledi
Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)
Today was a bittersweet day as I held my last clinic session @dukemedicine @DukeCancer. 12 yrs here - these are the halls where I gained my clinical acumen, grew into an oncologist, and developed some research skills. I am so sad and so grateful for every minute of these 12 yrs.
Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) tweet media
English
4
1
167
0